论文信息 - Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial. - 字舞流文

Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial.

Lisa M McShane | Robin D Harrington | Chih-Jian Lih | Courtney H Bouk | Rajyalakshmi Luthra | Savitri Krishnamurthy | Stanley R Hamilton | David J. Sims | Long P Le | James H Doroshow | A. Iafrate | J. Sklar | L. McShane | J. Doroshow | E. Polley | L. Le | S. Krishnamurthy | K. Finberg | B. Conley | P. M. Williams | M. Routbort | K. Patel | C. Lih | Hayley E Robinson | Robin D. Harrington | V. Datta | Kneshay N. Harper | Courtney H. Bouk | R. Luthra | P Mickey Williams | A John Iafrate | Rajesh R. Singh | Geeta S. Mantha | Z. Walther | J. Yau | Barbara A Conley | Rajesh R Singh | Mark J Routbort | Keyur P Patel | Eric C Polley | David J Sims | Zenta Walther | Kneshay N Harper | Vivekananda Datta | Jonathan Yau | Geeta S Mantha | Karyn Ronski | Karin E Finberg | Sandra Canosa | Hayley Robinson | Amelia Raymond | Jeffrey L Sklar | Karyn Ronski | Amelia Raymond | S. Canosa | S. Hamilton | R. Harrington | P. Williams | Zenta Walther | Jeffrey L. Sklar | Stanley R. Hamilton | J. H. Doroshow | J. Doroshow

[1] David J. Sims,et al. Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial. , 2016, The Journal of molecular diagnostics : JMD.

[2] Vicki Brower,et al. NCI-MATCH pairs tumor mutations with matching drugs , 2015, Nature Biotechnology.

[3] Asher Mullard,et al. NCI-MATCH trial pushes cancer umbrella trial paradigm , 2015, Nature Reviews Drug Discovery.

[4] Donavan T. Cheng,et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.

[5] Paul D. Williams,et al. Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in Solid Tumors12 , 2015, Neoplasia.

[6] Z. Tezak,et al. The first FDA marketing authorizations of next-generation sequencing technology and tests: challenges, solutions and impact for future assays , 2015, Expert review of molecular diagnostics.

[7] J. Doroshow,et al. Molecular analysis for therapy choice: NCI MATCH. , 2014, Seminars in oncology.

[8] Leming Shi,et al. Next-generation sequencing in the clinic: promises and challenges. , 2013, Cancer letters.

[9] Alex M. Fichtenholtz,et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing , 2013, Nature Biotechnology.

[10] Rashmi Kanagal-Shamanna,et al. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. , 2013, The Journal of molecular diagnostics : JMD.

[11] Joshua L. Deignan,et al. ACMG clinical laboratory standards for next-generation sequencing , 2013, Genetics in Medicine.

[12] Shashikant Kulkarni,et al. Assuring the quality of next-generation sequencing in clinical laboratory practice , 2012, Nature Biotechnology.

[13] C. Sander,et al. Genome Sequencing Identifies a Basis for Everolimus Sensitivity , 2012, Science.

[14] Whitney Wooderchak-Donahue,et al. Design and analytical validation of clinical DNA sequencing assays. , 2012, Archives of pathology & laboratory medicine.

[15] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.

[16] Emmanouil Collab. A map of human genome variation from population-scale sequencing , 2011, Nature.

[17] C. E. Pearson,et al. Table S2: Trans-factors and trinucleotide repeat instability Trans-factor , 2010 .

[18] K. Sirotkin,et al. The interactive online SKY/M‐FISH & CGH Database and the Entrez Cancer Chromosomes search database: Linkage of chromosomal aberrations with the genome sequence , 2005, Genes, chromosomes & cancer.

[19] E. S. Pearson,et al. THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL , 1934 .